4th Quarter - Report

CENCORA, INC. for CENCORA, INC.

Firm
Client
Income
—
Expenses
$775,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B.

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
RITA E NORTON —
ASHLEY ROSE O'SULLIVAN —
BRADFORD TALLAMY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2543 (116th)

Pharmacy PHA

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034 and S. 640, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 and H.R. 1614 John S. McCain Opioid Addiction Prevent Act.

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
RITA E NORTON —
ASHLEY ROSE O'SULLIVAN —
BRADFORD TALLAMY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3282 (116th), H.R. 6600 (116th), H.R. 1034 (116th), H.R. 1959 (116th), S. 640 (116th), S. 724 (116th), S. 988 (116th), H.R. 1607 (116th), H.R. 803 (116th), H.R. 1614 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.